The Globe and Mail reports in its Thursday edition that Desjardins's Chris MacCulloch still rates Whitecap Resources "buy." The Globe's David Leeder writes that Mr. MacCulloch hiked his share target by to $15 from $14. Analysts on average target the shares at $14.95. Mr. MacCulloch says in a note: "Whitecap delivered another solid quarter, augmenting its 'go-to' status for investors seeking exposure to liquids-rich Montney and Duvernay resource. Consistent operational execution and a measured approach to asset development have allowed the company to avoid operational missteps faced by several of its peers, including one of its predecessor entities while delivering modest organic growth. On the conference call, management highlighted that Kaybob is nearly a full year ahead of its production schedule while debottlenecking at Musreau is poised to unlock additional volumes later this year. ... The company is already laying the foundation for 'beat-and-raise' performance in 2026 after surpassing its 2025 production guidance target by 2 per cent." Given the "favourable" backdrop, Mr. MacCulloch now sees the potential for Whitecap to "revisit the M&A arena where it has historically created significant shareholder value."